SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-088937
Filing Date
2024-08-01
Accepted
2024-08-01 07:00:09
Documents
12
Period of Report
2024-07-31
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Document Format Files

Seq Description Document Type Size
1 8-K evok-20240731.htm   iXBRL 8-K 42205
2 EX-3.1 evok-ex3_1.htm EX-3.1 18915
  Complete submission text file 0000950170-24-088937.txt   179536

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT evok-20240731.xsd EX-101.SCH 24864
14 EXTRACTED XBRL INSTANCE DOCUMENT evok-20240731_htm.xml XML 4715
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36075 | Film No.: 241164152
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)